Good death for all remains distant goal

Ellershaw and colleagues again defend their Liverpool care pathway.1 The pathway has obvious appeal, but it has proved controversial, and reports of misuse remain disturbingly frequent.2 Despite decades of research in the care of patients with cancer, the accurate prediction of dying—the last 48 hours of life—remains difficult.3 Accuracy is …